000126588 001__ 126588
000126588 005__ 20240731103333.0
000126588 0247_ $$2doi$$a10.2147/IMCRJ.S391201
000126588 0248_ $$2sideral$$a134095
000126588 037__ $$aART-2023-134095
000126588 041__ $$aeng
000126588 100__ $$aLeón, Felix
000126588 245__ $$aEffects of dry needling on spasticity in multiple sclerosis evaluated through the rate-dependent depression of the H Reflex: a case report
000126588 260__ $$c2023
000126588 5060_ $$aAccess copy available to the general public$$fUnrestricted
000126588 5203_ $$aBackground: Spasticity is a common symptom of multiple sclerosis (MS) which affects mobility. Dry Needling (DN) has shown a reduction in spasticity in neuromuscular conditions such as stroke and spinal cord injury although the mechanism of action is still unclear. In spastic individuals, the Rate-Dependent Depression (RDD) of the H reflex is decreased as compared to controls and analyzing the effects of DN in the RDD may help to understand its mechanism of action. Objective: To evaluate the effect of Dry Needling on spasticity measured by the Rate-dependent Depression (RDD) of the H reflex in an MS patient. Methods: Three time points were evaluated: Pre-intervention (T1), Post-intervention assessments were carried out in the seventh week at two-time points: Before DN (T2) and After DN (T3). Main outcomes included the RDD and latency of the H reflex in the lower limbs at stimulation frequencies of 0.1, 1, 2, and 5 Hz in a five consecutive pulses protocol. Results: An impairment of the RDD of the H reflex at frequencies ≥ 1 Hz was found. Statistically significant differences were found when comparing the mean RDD of the H reflex in Pre-intervention compared to Post-intervention at 1, 2, and 5 Hz stimulation frequencies. Mean latencies were statistically lower when comparing Pre- vs Post-intervention.
Conclusion: Results suggest a partial reduction in spasticity represented by decrease of the excitability of the neural elements involved in the RDD of the H reflex following DN. The RDD of the H reflex could be implemented as an objective tool to monitor changes in spasticity in larger DN trials.
000126588 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000126588 592__ $$a0.267$$b2023
000126588 593__ $$aMedicine (miscellaneous)$$c2023$$dQ3
000126588 594__ $$a1.4$$b2023
000126588 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000126588 700__ $$aManzo, Leticia
000126588 700__ $$aKababie, Rebeca
000126588 700__ $$aFigueroa, Jimena
000126588 700__ $$aCuellar, Carlos
000126588 700__ $$0(orcid)0000-0002-9201-0120$$aHerrero, Pablo$$uUniversidad de Zaragoza
000126588 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000126588 773__ $$gVolume 16 (2023), 293-302$$tInternational Medical Case Reports Journal$$x1179-142X
000126588 8564_ $$s3359455$$uhttps://zaguan.unizar.es/record/126588/files/texto_completo.pdf$$yVersión publicada
000126588 8564_ $$s2599546$$uhttps://zaguan.unizar.es/record/126588/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000126588 909CO $$ooai:zaguan.unizar.es:126588$$particulos$$pdriver
000126588 951__ $$a2024-07-31-09:47:26
000126588 980__ $$aARTICLE